🔗 Permalink

Inventor profile of:

Roberta Cannella

City:

Varese

Country:

Italy

Published Applications:

39

Last publication date:

2026-01-29

Top Assignees for applications by Roberta Cannella

The entities that hold a legal rights for patent applications filed by inventor Cannella Roberta:

Helsinn Healthcare SA 23 Lugano/Pazzallo, Switzerland
Roche Palo Alto LLC 14 Palo Alto, CA United States
Helsinn Healthcare S.A. 7 Lugano, Switzerland
Helsinn Healthcare SA 6 Lugano/ Pazzallo, Switzerland
Helsinn Healthcare S.A. 3 Pambio-Noranco, Switzerland
Helsinn Healthcare S.A. 1 Lugano/Pazallo, Switzerland
Helsinn Healthcare SA 1 Pazzallo, Switzerland
HELSINN HEALTHCARE SA 1 Pambio-Noranco (Lugano), Switzerland
HELSINN HEALTHCARE SA 1 , Switzerland

Recent patent applications by Cannella Roberta

Roberta Cannella from Varese, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29

US20260027138A1

Human necessities

PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

#2 | 2025-07-24

US20250235473A1

Human necessities

PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

#3 | 2023-08-24

US20230263799A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#4 | 2023-06-08

US20230172953A1

Human necessities

Physiologically balanced injectable formulations of fosnetupitant

#5 | 2022-12-22

US20220401463A1

Human necessities

Process for the synthesis of substituted chloromethyl dialkylphosphates

#6 | 2021-04-08

US20210100794A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#7 | 2020-12-24

US20200399240A1

Chemistry; metallurgy

Fosnetupitant chloride hydrochloride having improved stability

#8 | 2020-07-02

US20200206249A1

Human necessities

Physiologically balanced injectable formulations of fosnetupitant

#9 | 2019-06-13

US20190177296A1

Chemistry; metallurgy

Substituted piperaziniums for the treatment of emesis

#10 | 2018-09-13

US20180256567A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#11 | 2018-07-12

US20180194788A1

Chemistry; metallurgy

Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator

#12 | 2018-07-12

US20180193262A1

Human necessities

LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON

#13 | 2017-12-07

US20170348335A1

Human necessities

Physiologically balanced injectable formulations of fosnetupitant

#14 | 2017-02-23

US20170050993A1

Chemistry; metallurgy

Substituted piperaziniums for the treatment of emesis

#15 | 2017-02-16

US20170042807A1

Human necessities

LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON

#16 | 2016-11-03

US20160317440A1

Human necessities

LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON

#17 | 2016-10-13

US20160296510A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#18 | 2016-05-19

US20160136162A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#19 | 2016-01-07

US20160000773A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#20 | 2015-10-29

US20150306032A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#21 | 2015-05-21

US20150141454A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#22 | 2015-01-08

US20150011510A1

Chemistry; metallurgy

4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

#23 | 2014-07-10

US20140194438A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#24 | 2014-07-10

US20140194395A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#25 | 2014-07-10

US20140193487A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#26 | 2014-04-10

US20140097114A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#27 | 2014-02-06

US20140039000A1

Human necessities

LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON

#28 | 2013-10-31

US20130289065A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#29 | 2013-10-10

US20130267553A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#30 | 2013-10-03

US20130261592A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#31 | 2013-10-03

US20130261150A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#32 | 2013-10-03

US20130261149A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#33 | 2013-09-05

US20130231315A1

Chemistry; metallurgy

Methods of treating emesis

#34 | 2013-04-23

US13478361

Substituted 4-phenyl pyridines having anti-emetic effect

#35 | 2012-03-15

US20120064153A1

Human necessities

Compositions and methods for treating centrally mediated nausea and vomiting

#36 | 2011-08-11

US20110192493A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#37 | 2006-07-27

US20060167073A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#38 | 2006-07-27

US20060167071A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

#39 | 2006-03-30

US20060069114A1

Human necessities

Liquid pharmaceutical formulations of palonosetron

InventorID:

425467 ⎘